← All stocks

Merck & Co.

MRK Net selling
CIK 0000310158 #311 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$72.01M
$0.00 on a plan · $42.61M straight out of an exercise
Sold at will
$29.41M
20 of 35 sales
Net
−$72.01M
−$29.41M against sales at will

By person

16 insiders · 50 transactions
36.9×

Robert M. Davis holds 36.9 times base salary in stock. $60.80M of shares against $1.65M in salary for 2025.

Salary from the company's own proxy. The shares are what Robert M. Davis last reported holding, valued at $135.00, the price Common Stock was last bought or sold at on the open market here, on 13 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Zachary Jennifer
EVP, General Counsel
$25.20M (4) scheduled
−$25.20M
45,509
0.0018%
$6.14M
+40.5%
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
$11.29M (9)
−$11.29M
110,167
0.0045%
$14.87M
−31.3%
Guindo Chirfi
EVP, Access, Policy & Comms
$8.15M (5)
−$8.15M
36,613
0.0015%
$4.94M
−16.5%
Williams David Michael
EVP,Chief Info&Digital Officer
$8.13M (5) scheduled
−$8.13M
31,716
0.0013%
$4.28M
+54.1%
Davis Robert M
Chairman, CEO & President
$5.60M (2)
−$5.60M
450,351
0.0183%
$60.80M
+29.3%
Litchfield Caroline
EVP & CFO
$5.02M (1) scheduled
−$5.02M
92,301
0.0037%
$12.46M
+80.9%
Li Dean Y
Executive VP & President, MRL
$2.99M (2) scheduled
−$2.99M
94,431
0.0038%
$12.75M
+92.0%
Maraldo David R.
EVP & Pres. MMD
$2.41M (3) scheduled
−$2.41M
18,212
0.0007%
$2.46M
+2.2%
Oosthuizen Johannes Jacobus
EVP, Oncology & Int?l
$1.83M (1)
−$1.83M
21,895
0.0009%
$2.96M
−10.3%
Smart Dalton E. III
SVP Fin. - Global Controller
$765.92K (2) scheduled
−$765.92K
9,388
0.0004%
$1.27M
+110.4%
Downing Cristal N
Chief Comm. & Public Afrs Ofcr
$616.40K (1)
−$616.40K
0
0.0000%
$0.00
Romanelli Joseph
President, Human Health Int?l
28,739
0.0012%
$3.88M
+37.9%
BAKER DOUGLAS M JR
Director
16,000
0.0006%
$2.16M
+1,500%
Chattopadhyay Sanat
Exe V-P & Pres. MMD
15,347
0.0006%
$2.07M
Larson Betty D
EVP, Chief HR Officer
13,774
0.0006%
$1.86M
THULIN INGE G
Director
2,933
0.0001%
$395.94K
+2,833%
Insider
Date
Role
Action
Shares
Price
Amount
Maraldo David R.
2 May 2026
EVP & Pres. MMD
Exercised, kept
552
$112.16
$61.91K
Smart Dalton E. III
2 May 2026
SVP Fin. - Global Controller
Exercised, kept
383
$112.16
$42.96K
Larson Betty D
30 Apr 2026
EVP, Chief HR Officer
Exercised, kept
11,350
$110.95
$1.26M
Smart Dalton E. III
30 Apr 2026
SVP Fin. - Global Controller
Exercised, kept
464
$110.95
$51.48K
Oosthuizen Johannes Jacobus
29 Apr 2026
EVP, Oncology & Int?l
Exercised, kept
1,377
$110.03
$151.51K
Davis Robert M
29 Apr 2026
Chairman, CEO & President
Exercised, kept
13,300
$110.03
$1.46M
Litchfield Caroline
29 Apr 2026
EVP & CFO
Exercised, kept
3,935
$110.03
$432.97K
Larson Betty D
29 Apr 2026
EVP, Chief HR Officer
Exercised, kept
2,085
$110.03
$229.41K
Zachary Jennifer
29 Apr 2026
EVP, General Counsel
Exercised, kept
2,951
$110.03
$324.70K
Li Dean Y
29 Apr 2026
Executive VP & President, MRL
Exercised, kept
4,722
$110.03
$519.56K
Smart Dalton E. III
29 Apr 2026
SVP Fin. - Global Controller
Exercised, kept
944
$110.03
$103.87K
Williams David Michael
29 Apr 2026
EVP,Chief Info&Digital Officer
Exercised, kept
1,377
$110.03
$151.51K
DeLuca Richard R.
29 Apr 2026
EVP&Pres, Merck Animal Heallth
Exercised, kept
2,518
$110.03
$277.06K
Chattopadhyay Sanat
29 Apr 2026
Exe V-P & Pres. MMD
Exercised, kept
2,597
$110.03
$285.75K
Guindo Chirfi
29 Apr 2026
EVP, Access, Policy & Comms
Exercised, kept
1,967
$110.03
$216.43K

What was left out

Form 4 filings counted 81
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 15
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 537,512
History held since 1 Sep 2016